QDEL – QuidelOrtho Corporation
QDEL
$14.78Name : QuidelOrtho Corporation
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $1,006,248,512.00
EPSttm : -16.69
QuidelOrtho Corporation
$14.78
QDEL — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
16.32
Margin Of Safety %
Put/Call OI Ratio
0.47
EPS Next Q Diff
-0.34
EPS Last/This Y
18.86
EPS This/Next Y
0.81
Price
14.78
Target Price
33.14
Analyst Recom
2.67
Performance Q
-48.88
Upside
-4,045.2%
Beta
0.95
Ticker: QDEL
19 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | QDEL | 22.61 | 0.33 | 21.00 | 6777 |
| 2026-03-03 | QDEL | 21.49 | 0.34 | 0.57 | 6839 |
| 2026-03-04 | QDEL | 21.18 | 0.34 | 0.08 | 6855 |
| 2026-03-05 | QDEL | 21.4 | 0.34 | 0.00 | 6857 |
| 2026-03-06 | QDEL | 20.84 | 0.34 | 0.95 | 6893 |
| 2026-03-09 | QDEL | 19.85 | 0.34 | 2.48 | 6940 |
| 2026-03-10 | QDEL | 19.3 | 0.36 | 0.62 | 7120 |
| 2026-03-11 | QDEL | 18.04 | 0.37 | 0.22 | 7376 |
| 2026-03-12 | QDEL | 17.91 | 0.37 | 0.29 | 7539 |
| 2026-03-13 | QDEL | 17.92 | 0.37 | 0.29 | 7539 |
| 2026-03-17 | QDEL | 19.13 | 0.36 | 2.34 | 7758 |
| 2026-03-18 | QDEL | 17.09 | 0.44 | 1.45 | 8421 |
| 2026-03-19 | QDEL | 16.58 | 0.43 | 1.21 | 8452 |
| 2026-03-20 | QDEL | 15.23 | 0.44 | 0.25 | 8749 |
| 2026-03-23 | QDEL | 16.54 | 0.46 | 0.38 | 7898 |
| 2026-03-24 | QDEL | 16.17 | 0.45 | 0.22 | 8045 |
| 2026-03-25 | QDEL | 16.09 | 0.45 | 1.45 | 8044 |
| 2026-03-26 | QDEL | 15.59 | 0.48 | 0.31 | 8272 |
| 2026-03-27 | QDEL | 14.8 | 0.47 | 1.74 | 8344 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
19 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-02 | QDEL | 22.60 | -36.4 | 1397.9 | 2.17 |
| 2026-03-03 | QDEL | 21.49 | -36.4 | 1357.2 | 2.17 |
| 2026-03-04 | QDEL | 21.18 | -36.4 | 1362.8 | 2.17 |
| 2026-03-05 | QDEL | 21.41 | -36.4 | 1366.8 | 2.17 |
| 2026-03-06 | QDEL | 20.84 | -36.4 | 1361.0 | 2.17 |
| 2026-03-09 | QDEL | 19.85 | -36.4 | 1357.9 | 2.17 |
| 2026-03-10 | QDEL | 19.28 | -36.4 | 1360.9 | 2.17 |
| 2026-03-11 | QDEL | 18.04 | -36.4 | 1355.6 | 2.17 |
| 2026-03-12 | QDEL | 17.93 | -36.4 | 1364.4 | 2.17 |
| 2026-03-13 | QDEL | 17.09 | -36.4 | 1358.7 | 2.17 |
| 2026-03-17 | QDEL | 19.12 | -36.4 | 1376.5 | 2.17 |
| 2026-03-18 | QDEL | 17.11 | -36.4 | 1349.9 | 2.17 |
| 2026-03-19 | QDEL | 16.59 | -36.4 | 1281.3 | 2.17 |
| 2026-03-20 | QDEL | 15.24 | -36.4 | 1272.7 | 2.17 |
| 2026-03-23 | QDEL | 16.54 | -36.4 | 1280.9 | 2.17 |
| 2026-03-24 | QDEL | 16.19 | -36.4 | 1278.7 | 2.17 |
| 2026-03-25 | QDEL | 16.03 | -36.4 | 1277.7 | 2.17 |
| 2026-03-26 | QDEL | 15.58 | -36.4 | 1274.7 | 2.17 |
| 2026-03-27 | QDEL | 14.78 | -36.4 | 1269.7 | 2.17 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
19 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-02 | QDEL | 7.64 | 1.62 | 15.11 |
| 2026-03-03 | QDEL | 7.64 | 1.62 | 15.11 |
| 2026-03-04 | QDEL | 7.64 | 1.62 | 15.11 |
| 2026-03-05 | QDEL | 7.64 | 1.62 | 15.11 |
| 2026-03-06 | QDEL | 7.64 | 1.62 | 15.11 |
| 2026-03-09 | QDEL | 7.64 | 1.60 | 15.11 |
| 2026-03-10 | QDEL | 7.64 | 1.60 | 15.11 |
| 2026-03-11 | QDEL | 7.64 | 1.60 | 15.29 |
| 2026-03-12 | QDEL | 7.64 | 1.60 | 15.29 |
| 2026-03-13 | QDEL | 7.64 | 1.60 | 15.29 |
| 2026-03-17 | QDEL | 7.64 | 1.87 | 15.29 |
| 2026-03-18 | QDEL | 7.64 | 1.87 | 15.29 |
| 2026-03-19 | QDEL | 7.64 | 1.87 | 15.29 |
| 2026-03-20 | QDEL | 7.64 | 1.87 | 15.29 |
| 2026-03-23 | QDEL | 7.64 | 1.87 | 15.29 |
| 2026-03-24 | QDEL | 7.64 | 1.87 | 15.29 |
| 2026-03-25 | QDEL | 7.64 | 1.87 | 16.32 |
| 2026-03-26 | QDEL | 7.64 | 1.87 | 16.32 |
| 2026-03-27 | QDEL | 7.64 | 1.87 | 16.32 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
19 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
0.46
Avg. EPS Est. Current Quarter
0.47
Avg. EPS Est. Next Quarter
0.12
Insider Transactions
7.64
Institutional Transactions
1.87
Beta
0.95
Average Sales Estimate Current Quarter
682
Average Sales Estimate Next Quarter
630
Fair Value
Quality Score
36
Growth Score
34
Sentiment Score
10
Actual DrawDown %
91.8
Max Drawdown 5-Year %
-91.3
Target Price
33.14
P/E
Forward P/E
5.09
PEG
0.29
P/S
0.37
P/B
0.52
P/Free Cash Flow
EPS
-16.66
Average EPS Est. Cur. Y
2.17
EPS Next Y. (Est.)
2.98
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-41.42
Relative Volume
1.65
Return on Equity vs Sector %
-86.3
Return on Equity vs Industry %
-70.8
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.29
EBIT Estimation
1269.7
◆
QDEL
Healthcare
$14.78
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
20/20
Pullback
5/25
Volume
0/15
Valuation
17/20
TP/AR
0/10
Options
4/10
RSI
28.4
Range 1M
0.4%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
14/25
Growth
13/30
Estimates
0/20
Inst/Vol
6/15
Options
3/10
EPS Yr
1.2%
EPS NY
35.5%
52W%
0.1%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+468.1% upside
Quality
4/30
Valuation
22/30
Growth
13/25
Stability
5/10
LT Trend
4/5
Upside
+468.1%
Quality
36
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Medical Devices
Employees: 6500
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.
QDEL
Latest News
—
Caricamento notizie per QDEL…
stock quote shares QDEL – QuidelOrtho Corporation Stock Price stock today
news today QDEL – QuidelOrtho Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch QDEL – QuidelOrtho Corporation yahoo finance google finance
stock history QDEL – QuidelOrtho Corporation invest stock market
stock prices QDEL premarket after hours
ticker QDEL fair value insiders trading